Refine your search
Collections
Co-Authors
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Surpur, Rajeshwari
- Post-operative Pulmonary Complications after Elective Abdominal Surgery
Abstract Views :214 |
PDF Views:0
Authors
Affiliations
1 Department of Surgical Oncology, S.S. Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
2 Department of Obstetrics and Gynecology, S.S. Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
3 Department of Forensic Medicine & Toxicology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
4 Dept. of Pharmacology, S.S Institute of Medical Sciences and Research Centre, Davangere- 577005, Karnataka, IN
5 Department of Microbiology, S.S Institute of Medical Sciences and Research Centre, Davangere- 577005, Karnataka, IN
1 Department of Surgical Oncology, S.S. Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
2 Department of Obstetrics and Gynecology, S.S. Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
3 Department of Forensic Medicine & Toxicology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
4 Dept. of Pharmacology, S.S Institute of Medical Sciences and Research Centre, Davangere- 577005, Karnataka, IN
5 Department of Microbiology, S.S Institute of Medical Sciences and Research Centre, Davangere- 577005, Karnataka, IN
Source
Indian Journal of Public Health Research & Development, Vol 3, No 1 (2012), Pagination: 114-117Abstract
The incidence of post operative pulmonary infection vary according to the definition of post operative complications and the surgical site.
Aim
Main aim is to study the incidence and various risk determinants of postoperative pulmonary complications following elective abdominal surgery.
Methodology
A total of 103 patients who had an elective abdominal surgery were assessed for complications.
Results
Among 103 patients, 24.27% developed postoperative pulmonary complications. More commonly the elderly men, obese, smokers, prolonged surgery time and midline vertical incision were other determinants for developing complications.
Conclusion
Adequate preoperative evaluation of pulmonary functions can reduce pulmonary morbidity in a high risk patient undergoing an elective abdominal surgery.
Keywords
Postoperative Complications, Pulmonary Complications
References
- Singh A, Purohit A, Joshi V, Sharma RS, Garg OP. Preoperative lung function tests. Best predictor to correlate post-operative pulmonary complications after upper abdominal surgery. Asian Archieves of Anaesthesiology and Resuscitation 1993;XXXIX(1).
- Bartholome R, Celli MD. What is the value of preoperative pulmonary function testing ? Medical clinics of North America 1993;309-325.
- Crozier TA, Sydow M, Siewart JR, Braun U. Post operative pulmonary complication Rate and Long Term changes in respiratory function following esophagogastrectomy with esophagogastrostomy. Acta Anaesthesiology Scand 1992; 36:10-15.
- Zibrak JD, O’Donnel CR, Marton K. Indications for pulmonary function testing. Annuals of Internal medicine. 1990;112(10).
- Latimer RG, Dickman M, Day WC et al. Ventilatory patterns and pulmonary complications after upper abdominal surgery determined by Pre-operative and post-operative computerized spirometry and blood gas analysis. Am J Surg 1971;122, 622.
- Park JE, Park K. Textbook of preventive and social medicine, 14th edition, Obesity 1998;255-258.
- Miller RD. Textbook of Anesthesia 4th edition.
- Wightman JAK. A prospective survey of the incidence of postoperative pulmonary complications. Br J Surg SS Feb 1998.
- Wylie, Churchill. Davidson’s – A practice of anaesthesia, 6th edition.
- Cross Sectional Survey of Burden of Illness in Terminally Ill Cancer Patients
Abstract Views :192 |
PDF Views:0
Authors
L. S. Patil
1,
Gayatri L. Patil
2,
H. H. Geetha
2,
Venkatesh M. Patil
3,
V. Vijayanath
4,
Rajeshwari Surpur
5
Affiliations
1 Department of Surgical Oncology, S.S. Institute of Medical Sciences & Research Centre Davangere 577005, Karnataka, IN
2 Department of Obstetrics and Gynecology, S.S. Institute of Medical Sciences & Research Centre Davangere 577005, Karnataka, IN
3 Dept. of Pharmacology, S.S. Institute of Medical Sciences & Research Centre Davangere 577005, Karnataka, IN
4 Department of Forensic Medicine & Toxicology, S.S. Institute of Medical Sciences & Research Centre Davangere 577005, Karnataka, IN
5 Dept. of Microbiology, S.S. Institute of Medical Sciences & Research Centre Davangere 577005, Karnataka, IN
1 Department of Surgical Oncology, S.S. Institute of Medical Sciences & Research Centre Davangere 577005, Karnataka, IN
2 Department of Obstetrics and Gynecology, S.S. Institute of Medical Sciences & Research Centre Davangere 577005, Karnataka, IN
3 Dept. of Pharmacology, S.S. Institute of Medical Sciences & Research Centre Davangere 577005, Karnataka, IN
4 Department of Forensic Medicine & Toxicology, S.S. Institute of Medical Sciences & Research Centre Davangere 577005, Karnataka, IN
5 Dept. of Microbiology, S.S. Institute of Medical Sciences & Research Centre Davangere 577005, Karnataka, IN
Source
Indian Journal of Public Health Research & Development, Vol 2, No 1 (2011), Pagination: 33-37Abstract
Introduction
Cancer is one of the leading causes of mortality in women, especially in the developing countries, where palliative care is not greatly emphasized.
Objectives
The primary objective is to analyse the various medical, ethical and legal issues faced by terminally ill gynaecological cancer patients. The other objectives being pain assessment, overall health related quality of life, economic issues and to determine preferences regarding decision making and information disclosure to patients.
Methods
A non interventional hospital based cross-sectional survey of 100 terminallly ill patients was conducted over a period of 2 years (March 2007 - April 2009).With an informed consent, the patient is asked to complete a questionaire.
Results-Medical problems
74% of patients had intolerable pain, so deprived of sound sleep. 98% of them suffered from some form of depression. Poor educational status and poverty made these patients highly dependable on family members for financial assistance (64%). Comparatively the more elderly patients experienced an inner fear, as they were neglected or abandoned by the care takers.
Ethical problems
With good doctor-patient relationship, communication about diagnosis and management was established in 50% of cases, but majority of them (81%) were not involved in decision making, which amounts to medical negligence.
Legal problems
None of the patients were aware of their legal rights during the course of their illness
References
- Dr. Partha Basu “Palliative care an integral part of cancer management”, Vol. VI, I, Indian Journal of Oncology, Page 5-13, (2006)
- Sepulveda et al., JPSM 2002,24:91-96.
- Reena George, “Evaluation of palliative care in developing countries”, Vol. II, I, Indian Journal of Palliative care, page 2-6 (2005).
- Ethical and legal issues surrounding palliative care, International conference on modern cancer management, July 2008;21-27.
- Euthanasia and physician assisted suicide, 2002, pg. 2-10, www.spuc.org.uk.
- www.worldtd.net/public/Israel_terminallyill_law.pdf
- Euthanasic and physician assisted suicide, 2002,pg 2- 10, www.spuc.org.uk.
- Pincombe et al (1997)
- Ethical and legal issues – International conference on modern cancer management, July 21-27, 2008.
- Current review of pain, Gerald et al. eds. Prithvi Raj, 2000.
- Christine faull et al., Handbook of palliative care, 2001.
- Transgenic Animals and Drug Development: a Review
Abstract Views :219 |
PDF Views:0
Authors
Venkatesh M. Patil
1,
Santosh N. Kugali
2,
Rajeshwari Surpur
3,
S. A. Dhanalaxmi
4,
M. R. Anitha
5,
V Vijayanath
6
Affiliations
1 Dept. of Pharmacology, S.S Institute of Medical Sciences and Research Centre, Davangere 577005 Karnataka, IN
2 Department of Pharmacology, M.S. Ramaiah Medical College, Bangalore, IN
3 Dept. of Microbiology, Sri Devraj Urs Medical College, Karnataka, IN
4 Department of Microbiology, Sri Devraj Urs Medical College, Karnataka, IN
5 Dept. of Anatomy, S.S. Institute of Medical Sciences, Karnataka, IN
6 Dept. of Forensic Medicine, S.S. Institute of Medical Sciences, Karnataka, IN
1 Dept. of Pharmacology, S.S Institute of Medical Sciences and Research Centre, Davangere 577005 Karnataka, IN
2 Department of Pharmacology, M.S. Ramaiah Medical College, Bangalore, IN
3 Dept. of Microbiology, Sri Devraj Urs Medical College, Karnataka, IN
4 Department of Microbiology, Sri Devraj Urs Medical College, Karnataka, IN
5 Dept. of Anatomy, S.S. Institute of Medical Sciences, Karnataka, IN
6 Dept. of Forensic Medicine, S.S. Institute of Medical Sciences, Karnataka, IN
Source
Indian Journal of Public Health Research & Development, Vol 2, No 1 (2011), Pagination: 106-109Abstract
Pharmaceutical companies face the challenge that only ten percent of compounds tested in clinical trials eventually make it to the market and out of these, only a few will succeed to generate profit. Utilization of genetically altered animals (transgenic animals) in the pharmaceutical industry provides important insights into the function and interaction of particular gene products. Now, with the help of advanced technology numerous transgenic animals have been produced. The advent of transgenic animals has influenced the attrition rate in pharmaceutical research and development by increasing the quality of both targets and compounds. As with any experimental animal model, transgenic animals also have certain limitations but still they provide a powerful tool for the advancement of drugs in the pharmaceutical industry.Keywords
Animals, Experiment, DrugReferences
- Luthra PM, Singh J, Kumar R, Singh S. Role of Geneknockout Strategy in New drug Discovery. In: Kohli K, Gupta M, Tejwani S editors. Contemporary Perspectives on Clinical Pharmacotherapeutics. Elsevier, 2006:124-144.
- Paigen K, Eppig JT. A mouse phenome project. Mamm. Genome, 2000, 11: 715-717.
- Marks CL. Animal Models for Human Diseases: Is There a Future Without Them? The Journal of Nuclear Medicine Dec 2006, 47(12):50N-51N.
- Jaenisch R, Mintz B. Simian virus 40 DNA sequences in DNA of healthy adult mice derived from preimplatation blastocysts injected with viral DNA. Proc. Natl. Acad. Sci. USA 1974, 71:1250-1254.
- Palmiter RD, Brinster RL, Hammer RE, et al. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 1982, 300:611-615.
- Palmiter RD, Norstedt G, Gelinas RE, Hammer RE, Brinster RL. Metallothionein-human GH fusion genes stimulate growth of mice. Science 1983, 222: 809-814.
- Thomas KR, Capecchi MR. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987; 51(3):503-512.
- Misra RP, Duncan SA. Gene targeting in the mouse. Endocrine Dec 2002.19(3):229-238.
- Gulezian D, Kram DJ, McCollough B, et al. Use of transgenic animals for carcinogenicity testing: Considerations and Impications for risk assessment. Toxicologic Pathology 2000; 28(3):482-499.
- Picciotto MR, Wickman K. Using knockout and transgenic mice to study neurophysiology and behaviour. Physiological Reviews Oct 1998;78(4):1131- 1155.
- Bowers BJ. Applications of transgenic and knockout mice in alcohol research. Alcohol research & Health 2000; 24(3):175-183.
- Lim KI, Dumenco LL, Yun J. et al. High level regulated expression of the chimeric P-enolpyruvate carboxykinase gene in transgenic mice. Cancer Res 1990; 50:1701-1708.
- Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad Sci.USA 1992; 89:5547- 5551.
- Sauer B, Henderson N. Site specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl Acad Sci. USA 1988; 85:5166-5170.
- Folkesson R, Winbald B, Benedikz E. Alzheimer transgenic models. Curr Opin Psychiatry 2002; 15:433- 439.
- Gupta SK. Drug Screening Methods 2004; Jaypee Publishers, New Delhi: 97-99.
- Deltour L et al. Journal of Biochemistry 1999; 274:16796-16801.
- Hodge CW, Mehmert KK, Kelley SP et al. Supersensitivity to allosteric GABAA receptor modulators and alcohol in mice lacking PKCå. Nature Neuroscience 1999;2:997-1002.
- Powell-Braxton L, Veniant M, Latvala RD et al. A mouse model of human familial hypercholesterolemia: markedly elevated LDL and severe atheroscelrosis on a low fat chow diet. Nat Med 1998; 4:934-938.
- Coleman DL. Obese and diabetes, two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978; 14:141-148.
- Peterson RG, Shaw WN, Neel M-A et al. Zucker diabetic fatty rat as a model for noninsulin-dependent diabetes mellitus. ILAR News 1990; 32:16-19.
- Thurlby PL, Trayhurn P. The development of obesity in preweanling (ob/ob) mice. Br J Nutr 1978; 39:397-402.
- Crofford OB, Davis CK Jr. Growth characteristics, glucose tolerance and insulin sensitivity of New Zealand Obese mice. Metabolism 1965; 14:271-280.
- Ghosh MN. Fundamentals of experimental pharmacology 3rd edn. Hilton & Company publishers, Kolkata 2005:8-9.
- Mockrin SC, Dzau VJ, Gross KW, Horan MJ. Transgenic animals new approaches to hypertension research. Hypertension 1991; 17(3):394-399.
- Rudmann DG, Durham SK. Utilization of genetically altered animals in the Pharmaceutical industry. Toxicologic Pathology 1999; 27(1):111-114.
- Srinivasan K, Ramarao P. Animal models in type-2 diabetes research: An overview. Ind J Med Res, mar 2007; 125:451-472.
- Internet resource obtained from URL: http:// www.jax.org/resources/documents/imr/ 29. Internet resource obtained from URL: http:// tbase.jax.org.